← Company intelligence

Robot maker · registered

Virtual Incision

Corporate marketmedicalCurated record

Builds MIRA (Miniaturized In vivo Robotic Assistant), the first miniaturized robotic-assisted surgery device to receive FDA marketing authorization (De Novo pathway, February 2024, colectomy indication). The ~2 lb self-contained surgical robot is inserted through a single midline umbilical incision and is portable enough to make any OR robot-ready in minutes, versus mainframe surgical robots. Spun out of University of Nebraska research by Shane Farritor and surgeon Dmitry Oleynikov; the platform is AI-enabled (featured at NVIDIA GTC; exploring NVIDIA Isaac for Healthcare) and was used in a U.S. remote robotic-assisted surgery demonstration in November 2024 with Sovato, City of Hope and University of Illinois Chicago. Commercialization began via a First Access Program at select U.S. centers, with gynecology, general surgery and urology indications in the pipeline.

HeadquartersLincoln, US
Founded2006
Corporate funding$76M
TeamNot listed
Deployments2
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries C (extended)
FoundersShane Farritor (Co-Founder), Dmitry Oleynikov (Co-Founder)
Regions servedNorth America, Europe
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-21
MX

Robot models

Specifications remain vendor-claimed

Machineamr

M2

  • No specifications on file.
Machinemedical

MIRA Surgical System

  • Approximately two-pound miniaturized robotic-assisted surgery device inserted through a single midline umbilical incision in the abdomen

    Device weight and single-incision surgical access approach

    Claim source
  • First miniaturized robotic-assisted surgery device to receive FDA marketing authorization (De Novo pathway, colectomy indication in adults)

    Regulatory status and cleared indication

    Claim source
  • Portable design with minimal setup time, intended to make any operating room robot-ready within minutes

    Deployment footprint versus mainframe surgical robots

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2024-07-30Geneva University Hospitalshospital (first hysterectomy with MIRA; international prospective clinical study)CHNot disclosedAnnouncement
2021-08-16Bryan Medical Centerhospital (IDE clinical study, world-first MIRA surgery)USNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordEndeavour VisionBaird CapitalBluestem Capitalcultivate(MD) Capital FundsPrairieGold Venture PartnersArboretum Ventures
TL

Company timeline

Milestones and announcements

2024-02-24FDA grants De Novo marketing authorization for MIRA, the first miniaturized robotic-assisted surgery device (colectomy indication); commercialization begins via First Access Program at select U.S. centersVirtual Incision
2021-08-16World's first surgery with the MIRA platform: robotically assisted right hemicolectomy performed by Dr. Michael A. Jobst at Bryan Medical Center under an FDA Investigational Device ExemptionBusiness Wire
SC

Source ledger

6 unique public sources